| Application no. and date | 16705684.5 (espacenet) (Federated) (European Patent Register), 20160205 | | Patent/reg. no. and date | DK/EP 3253752, 20230816 | | Publication date | 20171213 | | Priority no. and date | US 201562113316 P, 20150206 | | EP pub. no. and date |
EP 3253752 20171213 | | Effective date | | | Applicant/owner | NEUROCRINE BIOSCIENCES, INC., 12780 El Camino Real
San Diego, CA 92130, US | | Applicant ref. no. | | | Inventor | ASHWEEK, Neil, 1802 Craigmore Avenue
Escondido, California 92027, US,
HARRIOTT, Nicole, 11340 Squamish Road
San Diego, California 92126, US | | Representative | | | Opponent | | | IPC Class | C07D 455/04 (2006.01) | | Title | [9,10-DIMETHOXY-3-(2-METHYLPROPYL)-1H,2H,3H,4H,6H,7H,11BH-PYRIDO-[2,1-A]ISOQUINOLIN-2-YL]METHANOL AND COMPOUNDS, COMPOSITIONS AND METHODS RELATING THERETO | | Int. application no. | US2016016892 | | Int. publication no. | WO2016127133 | | Related patent (certificate) | | | Status | Enhedspatent registreret | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
